|
|
Article: After Reagan's Death, Pressure Mounts For Human ESC Reform.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Washington Editor
WASHINGTON - So far, it doesn't appear that the Bush administration will lift restrictions on federally funded human embryonic stem cell research despite mounting pressure that has followed the death of former President Ronald Reagan.
President Bush has not shown any signs of loosening his grip on the controversial research even though former first lady Nancy Reagan called for an expansion of such research, which is believed might be useful in discovering treatments for Alzheimer's disease, Parkinson's disease, heart disease, diabetes and multiple sclerosis. Others say there are alternative approaches and therapies that abrogate the ...
Related newspaper, magazine, and journal articles:
|
|
Article: COMPANY FORGING AHEAD WITH DIABETES DRUG AMYLIN STOCK DROPS 77 ...
BIOWORLD Today;
October 22, 1998 ;
700+ words
... ... price dropped below $8.50. (See BioWorld Today, Aug. 19, 1997, p. 1.) Along ... U.S. and Europe," Krawiec told BioWorld Today. Tanner said Amylin's move to continue ... J $36 million from a loan. (See BioWorld Today, March 3, 1998, p. 1.) Terms ...
|
|